Kumagai K, Gondo N, Matsuo K, Annoura M, Moroe K, Nakashima Y, Hiroki T, Arakawa K
Department of Internal Medicine, School of Medicine, Fukuoka University, Japan.
Cardiology. 1994;85(3-4):184-92. doi: 10.1159/000176674.
We investigated whether the new parameter wavelength index could predict the response to chronic disopyramide therapy in patients with paroxysmal atrial fibrillation (AF). Twenty-seven patients with AF underwent electrophysiologic studies and the wavelength index was determined before and after intravenous administration of disopyramide. Then all patients were treated with oral disopyramide for 6 months. In 17 patients, AF was eliminated (group A), while it persisted in another 10 patients (group B). The ratio of the wavelength index before and after intravenous disopyramide was higher in group A than in group B. Thus, the wavelength index proved useful for predicting the response of AF to disopyramide.
我们研究了新参数波长指数是否能够预测阵发性心房颤动（AF）患者对慢性丙吡胺治疗的反应。27例AF患者接受了电生理研究，并在静脉注射丙吡胺前后测定了波长指数。然后所有患者口服丙吡胺治疗6个月。17例患者的AF消失（A组），而另外10例患者的AF持续存在（B组）。A组静脉注射丙吡胺前后的波长指数比值高于B组。因此，波长指数被证明可用于预测AF对丙吡胺的反应。
